LabVantage Marks Record Software Deployments in FY 2024

LabVantage Solutions, Inc., a leading provider of laboratory IT solutions, has announced the completion of over 100 software deployments in fiscal year 2024 across various industries, including pharmaceuticals, biotechnology, healthcare, oil and gas, and food and beverage.

The global LIMS market for life sciences, currently valued at $1 billion, is projected to grow at an annual rate of 12-14% in the coming years, driven by a 10-12% annual increase in users. In response to this evolving industry landscape, LabVantage has developed tailored LIMS solutions that integrate seamlessly with ELN, LES, and SDMS, providing a unified laboratory informatics platform.

LabVantage’s professional services organization has played a pivotal role in supporting customers globally, resulting in a more than 50% increase in global software deployments year-over-year.

Successful implementations of LabVantage LIMS over the past year can be classified into three main categories:

  1. Transition to Automated Data Management: Customers have shifted from manual recording processes to LabVantage’s LIMS platform for improved data management, extraction, and traceability.
  2. Upgrade to Advanced LIMS: Organizations previously using in-house LIMS systems or other commercial solutions with limited functionality have adopted LabVantage LIMS to enhance capabilities.
  3. Expansion of Existing LIMS Usage: Customers already using LabVantage LIMS have expanded its usage to other laboratories, recognizing its effectiveness in improving productivity.

Craig Bowie, Vice President of Professional Services at LabVantage Solutions, emphasized the company’s expertise in supporting customers across diverse industries. He highlighted the tangible improvements in operational productivity that customers experience through LabVantage solutions, attributing the company’s exceptional growth in software deployments to its commitment to customer success.

Source link

Newsletter Updates

Enter your email address below and subscribe to our newsletter